4Moving Biotech Announces First Patient Enrolled in Phase I Clinical Trial on Osteoarthritis
LILLE, France–(BUSINESS WIRE)– 4Moving Biotech, a biotechnology company and subsidiary of 4P-Pharma, focusing on the development of a first-in-class disease modifying osteoarthritis drug (DMOAD) for...